Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart ...
MedPage Today on MSN
Aortic stenosis patients still tripped up by diagnosis issues on the path to AVR
Results of care registry released with new TAVR national coverage determination on the hor ...
A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...
BACKGROUND: Undertreatment and delayed treatment of aortic stenosis (AS) are common, both of which are associated with increased mortality. Historically, assessment of quality for AS care has focused ...
In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing ...
NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...
After a torrid 12 months, most of the leading ASX stocks rallied in June despite a lack of clear company-specific catalysts ...
Boston Scientific Corporation (NYSE:BSX) is one of the oversold tech stocks to buy now. On May 18, Boston Scientific invested ...
Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.
Edwards today presented new data at New York Valves 2026 supporting its transcatheter aortic valve replacement (TAVR) ...
The Optimum TAVI system has been named “Top Aortic Valve Implantation System 2026” by the publication MED TECH Outlook. A detailed interview of Dr. Thubrikar, author of the 1991 textbook “The Aortic ...
Women receiving transcatheter aortic valve implantation face higher periprocedural complication risks but better long-term survival than men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results